Filamin A-Hinge Region 1-EGFP: A Novel Tool for Tracking the Cellular Functions of Filamin A in Real-Time by Planagumà, Jesús et al.
Filamin A-Hinge Region 1-EGFP: A Novel Tool for
Tracking the Cellular Functions of Filamin A in Real-Time
Jesu´s Planaguma`1.¤a, Laura Minsaas1.¤b, Mo´nica Pons2, Lene Myhren1, Georgina Garrido2,
Anna M. Aragay1,2*
1Department of Biomedicine, University of Bergen, Bergen, Norway, 2 Institut de Biologia Molecular de Barcelona, CSIC, Barcelona, Spain
Abstract
Background: Filamin A (FLNa) is an actin-crosslinking protein necessary for stabilizing the cell surface, organizing protrusive
activity and for promoting efficient cellular translocation. Recently, our group demonstrated the requirement of FLNa for the
internalization of the chemokine receptor CCR2B.
Methodology and Principal Findings: In order to study the role of FLNa in vitro and in real-time, we have developed a
fluorescent FLNa-EGFP construct. In this novel imaging tool, we introduced the EGFP-tag inside the flexible hinge 1 region
of FLNa between two calpain cleavage sites. Our findings indicate that the FLNa-EGFP construct was correctly expressed,
cleaved by calpain and colocalized with actin filaments as shown by immunostaining experiments in the human melanoma
cell lines A7 (FLNa-repleted) and M2 (FLNa-deficient). In addition, scanning-electron microscopy (SEM) and micropatterning
studies also provided clear evidence that the cell rigidity was restored. FLNa-EGFP allowed us to demonstrate the interaction
of FLNa with the chemokine receptor CCR2B in endocytic vesicles after CCL2 ligand stimulation. Through live-cell imaging
studies we show that the CCR2B receptor in Rab5-positive vesicles moves along filamin A-positive fibers.
Significance: Taken together, these results outline the functionality of the FLNa-EGFP and the importance of filamin A for
receptor internalization and movement into endocytic vesicles.
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Introduction
Filamin A (FLNa), previously known as ABP-280, is the most
widely expressed and most potent actin filament-crosslinker in a
family of actin-binding proteins (ABP) and is critically involved in
both locomotion and cell rigidity [1]. Structurally, FLNa is
comprised of three defined structures: an N-terminal actin-binding
domain (ABD), a rod-shaped domain composed of twenty-four
tandem immunoglobulin (Ig)-like repeats of ,96 amino acids each
[1,2,3] and two hinge regions, which each contain a cleavage site
for the calcium-dependent protease calpain. Hinge 1 (H1)
connects repeats 15–16 and Hinge 2 (H2) connects repeats 23–
24, providing filamins with their characteristic V-shaped flexible
structure [2,4]. The H1 region also divides the rod-shaped domain
into two subdomains, Rod 1 (repeats 1–15) and Rod 2 (repeats 16–
24). The N-terminal ABD consists of two calponin homology
(CH1 and CH2) domains containing three principal actin-binding
sites [5,6], while the 24th C-terminal Ig-like domain is the
dimerization domain, which is crucial for the actin-crosslinking
function of filamins [7].
Filamins also have other functions besides their F-actin cross-
linking ability. In fact, FLNa has over sixty reported intracellular
interaction partners, including membrane receptors, signalling
intermediates, enzymes, ion channels, and transcription factors
[8,9]. The diversity of the binding partners of the FLNa protein
makes it difficult in principle to evaluate the physiological
significance of those interactions as a whole. Nevertheless, when
the interaction partners are classified, it becomes apparent that a
vast majority of these include membrane proteins like the b-
integrins [10,11,12] and the extracellular calcium receptor
[13,14], signalling proteins such as the family of small GTPases
Rac, Rho and Cdc42 [15], or transcription factors like the
androgen receptor [16]. This observation suggests that FLNa
provides mechanical stability to the cell membrane and maintains
cell-cell and cell-matrix connections by tethering membrane
receptors to the actin cytoskeleton. In addition, FLNa may play
an important role as a scaffold by facilitating and coordinating
cellular processes, especially those involved in actin polymeriza-
tion.
The vast majority of the proteins that bind to FLNa interact
with the Rod 2 domain of the protein [9]. This is also the case for
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the CC-chemokine receptor CCR2B, which we recently identified
as a direct interaction partner of FLNa. According to our findings,
FLNa is required for the efficient ligand-induced internalization of
the receptor and possibly also for other downstream processes
involving the receptor [17]. Interestingly, the CCR2B receptor is
not the only chemokine receptor that binds to FLNa. The CCR5
and CXCR4 receptors have also been found as partners for
filamin, though they interact with different repeat structures of the
FLNa protein [18]. Additionally, CD4 also interacts with FLNa
[18] and CCR5, which then functions as a structural adaptor for
CD4 and chemokine receptor clustering in T cells. On the other
hand, CD28 requires FLNa binding to induce T-cell cytoskeletal
rearrangements in the immunological synapse [19]. So FLNa
appears to be particularly important for the physiological
responses induced by chemokine receptors and for the immuno-
logical responses. Moreover, a growing number of other GPCRs
have lately been associated with this actin-binding protein,
suggesting new physiological responses in which FLNa might play
an important role.
In order to obtain a molecular tool that would help to study the
physiological functions of FLNa, we have developed a fluorescent
FLNa fusion construct, which could be used for visualizing its
dynamics employing live-cell imaging. As the N-terminal domain
of FLNa is critical for actin-binding and the C-terminal domain is
involved in dimerization and binding to multiple intracellular
interaction partners, we chose to place the EGFP-tag in the
flexible H1 region, to avoid blocking any of these important
physiological functions of FLNa. Our findings indicate that the
FLNa-EGFP construct was correctly expressed and colocalized
with actin filaments, providing rigidity to the cells. Furthermore,
the fusion protein was able to bind and internalize the chemokine
receptor CCR2B upon CCL2-stimulation in Rab5-positive
vesicles. The ligand-stimulated ß2-adrenergic receptor also inter-
nalized along FLNa-positive vesicles at early times. In summary,
FLNa-EGFP is a novel imaging tool that will help to understand its
multiple functions in the cell, and especially to follow the
internalization of membrane receptors.
Results
FLNa-EGFP was successfully expressed in cells and
cleaved by calpain
Filamin A is involved in a multitude of cellular processes such as
cell migration, protein trafficking, transcriptional regulation and
mitosis [9]. The ability of FLNa to crosslink actin filaments, to
dimerize, and to interact with intracellular partners is crucial for
theses processes. In our quest to design an in vitro fluorescent FLNa
imaging tool, it was thus important to choose a cloning strategy
that would prevent compromising any of its physiological
functions. We therefore selected the flexible hinge 1 region as a
target for the insertion of a fluorescent EGFP tag. The hinge 1
region harbours one of the two calpain-cleavage sites in FLNa, the
other being located 10 kDa from the carboxy-terminal end in the
hinge 2 region [1]. To avoid masking the calpain cleavage site of
FLNa, which among other things is important for the solation of
focal adhesions at the uropod during cell migration [20,21], we
flanked the EGFP-tag with two small linker regions, and placed
the tag close to the beginning of the H1 sequence (Figure 1B). To
ensure that the FLNa-EGFP protein would be cleaved in the H1
region, we also introduced an artificial calpain-cleavage site in the
linker region in front of the EGFP-tag (Figure 1A and B). As can
be observed in the EGFP-tag model (Figure 1C), the insertion of
EGFP in the flexible H1 region between repeats 15 and 16, would
probably not compromise the structure of the FLNa protein
(Figure 1C). Western blot analyses from A7 (FLNa-repleted) and
M2 (FLNa-deficient) cells, transiently transfected with the FLNa-
EGFP or an empty vector, revealed that the FLNa-EGFP fusion
protein was expressed and migrated at its predicted size (Figure 1D,
upper bands in both panels), just above the endogenous FLNa
band (left panel). The construct could be detected using antibodies
targeted against FLNa (left panel) and GFP (right panel),
confirming the in-frame insertion of EGFP in the hinge 1 region.
Interestingly, the FLNa-EGFP construct was cleaved by calpain
either before (right panel, lower band) or after (right panel, middle
band) the EGFP-tag. The naturally cleaved calpain-band of
endogenous FLNa can be seen in the left panel of Figure 1D. So
the results indicated that the chimeric protein was expressed and
that the insertion of EGFP does not interfere with the normal
calpain-cleavage of FLNa in the H1 region.
FLNa-EGFP colocalizes with actin and is present in the
same subcellular locations as endogenous FLNa
Next it was important to assess the functionality of the FLNa-
EGFP protein. As mentioned before, FLNa is an actin-crosslinking
protein which colocalizes with actin structures in the cell. So,
immunofluorescence experiments could give us the first clues of
the performance of this chimeric protein. Again we took the
advantage of expressing the chimeric fluorescent protein in the
filamin-depleted M2 cells. First, M2 cells were transiently
transfected with either FLNa-EGFP (Figure 2A, third row of
panels) or wild type FLNa (second row of panels), and cells were
stained for actin with Rhodamine-phalloidin. The images show a
clear colocalization of EGFP- and endogenous filamin A with actin
(see merged image and colocalization) indicating that FLNa-EGFP
displayed the same subcellular localization pattern as endogenous
FLNa in A7 cells (lower panels). Moreover, staining M2-FLNa-
EGFP cells with anti-FLNa antibody resulted in a perfect
colocalization of both fluorescent labels, which again supports
the idea that the chimeric protein is correctly expressed and
detectable with anti-FLNa antibodies (Figure 2B). Untransfected
M2 cells were as expected devoid of FLNa (upper panels). This
confirms the first indication that the actin-binding function of
FLNa-EGFP is preserved and that it has not been compromised by
the fluorescent tag.
A7-like morphology is restored in cells expressing FLNa-
EGFP
While the FLNa-repleted A7 cells are dispersed before growing
to confluency and characterized by an elongated morphology with
the occurrence of surface stress fibres, FLNa-deficient M2 cells are
known for growing in cohesive colonies, for their lack of actin fibre
bundles and for their extensive membrane blebbing due to cell
surface instability [22,23]. In order to get a more detailed picture
of the structural consequences of introducing FLNa-EGFP into
FLNa-deficient cells, we used scanning electron microscopy (SEM)
in combination with fluorescence microscopy. High-resolution
SEM and fluorescent images revealed that the morphology of
FLNa-EGFP-expressing cells (Figure 3A, upper right and bottom
panels) was clearly A7-like (Figure 3A and B), displaying typically
elongated cells with stress fibres and a clear reduction in surface
blebbing compared to the FLNa-deficient M2 cells (Figure 3B).
Also worth noticing, was the perfect correspondence between
FLNa staining and the stress fibre structures (Figure 3B, upper
right panel). These findings suggest again that FLNa-EGFP is able
to crosslink actin like the wild-type FLNa.
From the mixed population of M2 cells stably expressing the
construct, we isolated a population of cells expressing medium and
FLNa-Hinge 1 Region EGFP
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high levels of fluorescence using flow cytometry. This population
was then serially diluted in order to isolate individual clones.
Careful observations of the cells using regular light-microscopy
and fluorescence microscopy (Figure S1 A), in combination with
analyses of cell lysates (Figure S1 B), showed that clones with lower
levels of fluorescence and protein expression behaved more M2-
like, displaying more blebbing and a tendency to grow in cohesive
colonies (data not shown). On the other hand, cells with too high
levels of FLNa, like C4, showed a tendency to grow in circular
patterns. Cells that had FLNa expression levels similar to the levels
found in A7 cells had a more elongated morphology (e.g. clones 5
(C5) and 8 (C8)) (Figure S1 A and B). Clone 8 had many elongated
Figure 1. Structure of the FLNa-EGFP construct. (A) Schematic representation of the structures of wild-type human FLNa (upper drawing) and
the FLNa-EGFP fusion construct (lower drawing). The region of interaction with CCR2B and the site of insertion of the EGFP-tag in the Hinge 1 region
(H1) are indicated. (B) Amino acid sequence of the hinge 1 region of FLNa-EGFP. The EGFP-tag is flanked by two Hind III cassettes (pink). Scissors
point to the natural (in the Hinge 1) and artificially inserted (in the first Hind III cassette) calpain-cleavage sites. (C) Homology modeling prediction of
the fragment comprising FLNa repeats 15 and 16 flanking the hinge 1 region with EGFP integrated in the middle. Modeling was accomplished using
the SWISS-model server. (D) Immunoblots showing the expression of FLNa-EGFP. A7 and M2 cells were transiently transfected with pcDNA3.1-FLNa-
EGFP (+FLNa-EGFP) or empty pcDNA3.1 (Ctrl). Blots were probed with anti-FLNa or anti-GFP antibodies as indicated. Black lines indicate the migration
bands of full-length monomeric FLNa-EGFP, endogenous FLNa and calpain-cleaved FLNa and FLNa-EGFP. Blots are representative of at least three
independent experiments.
doi:10.1371/journal.pone.0040864.g001
Figure 2. FLNa-EGFP colocalizes with actin at the membrane and in fibres. (A) Confocal images of FLNa, FLNa-EGFP and actin expression in
cells after immunostaining. M2 cells transiently transfected with pcDNA3.1-FLNa-EGFP or pREP4-FLNa and untransfected A7 and M2 cells, were
seeded on top of glass coverslips, fixed, permeabilized, incubated with anti-FLNa and goat anti-mouse Alexa Fluor 488 and stained with rhodamine-
phalloidin before mounting. (B) Confocal images of FLNa-EGFP expression in M2 cells transiently transfected with pcDNA3.1-FLNa-EGFP. Cells were
seeded on top of glass coverslips, fixed, permeabilized and incubated with anti-FLNa and Texas Red goat anti-mouse. All images are from one single
layer of the Z stacks. The colocalization between (green) and (red) was analyzed using Imaris colocalization software and is shown in white. Images
are representative of at least three independent experiments. Scalebars (10 mm).
doi:10.1371/journal.pone.0040864.g002
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cells with a high occurrence of surface stress fibres, but the cells in
this clone also seemed to actively round up and cluster and did not
grow as fast as the A7 cells. These results show the importance of
the levels of FLNa for the viability and functionality of the cell.
Cell rigidity in the clonal cells is restored to the levels of
A7 cells
It has recently been shown that due to their lack of FLNa, M2
cells are twice as soft as, more fluid-like, and exert much smaller
contractile stress on the substratum than the more rigid FLNa-
expressing A7 cells [24]. To determine if FLNa-EGFP could
restore the rigidity in M2 cells, we chose to compare the structural
behavior of A7, M2 and cell clone C5 using the new fibronectin
micropatterning technology, recently commercialized by CY-
TOO. Clone C5 had similar levels of FLNa expression and similar
morphology compared to A7 cells. So we used this clone for cell
rigidity analyses. The cell shaped images showed that M2 cells
were able to draw well-defined T and I shapes compared to the A7
cells and clone C5 (Figure 4A). To quantify the rigidity of the cells,
the measurement of the area (in pixels) of the cell attached to the
pattern was taken and divided by the area of the fibronectin
pattern. A ratio equal to one would mean a perfect overlap with
Figure 3. FLNa-EGFP restores the A7-like morphology in M2 cells. (A) (Upper panels) SEM images of A7 and M2 cells and mixed M2 FLNa-
EGFP cell population (magnification 40x). (Lower panels, left) Fluorescent image combined with bright-field image of M2 cells expressing FLNa-EGFP
(magnification 40x). (Lower panels, right) Confocal microscopy image of M2 cells expressing FLNa-EGFP processed with Imaris (scalebar: 10 mm). (B)
(Upper panels) SEM and fluorescent correlation microscopy: Image from the same cell taken by SEM and fluorescent microscopy and overlapped with
adobe photoshop (scalebars: 10 mm). (Lower panels) SEM images of A7 and M2 cells (scalebar: 10 mm).
doi:10.1371/journal.pone.0040864.g003
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Figure 4. Cell rigidity restored by FLNa-EGFP. (A) Micropatterning assay showing two fibronectin shape types (T and I) covered by M2, A7 and
C5 (clone with FLNa levels resembling those of A7 cells). Images taken by confocal microscopy are from one single layer of the Z stacks. FLNa-EGFP
and FLNa are shown in green, actin in red and the colocalization channel, calculated with the Imaris software, in white (scalebars: 10 mm). (B) Detail of
M2 and C5 cells showing the actin fibre curvature over the micropattern shape. (C) The size of the area in pixels of the A7, M2, and C5 cells attached
to the pattern was divided by the area of the fibronectin shape and given as ratio (area cell/area fibronectin) (Ratio close to 1 = area covered by cell is
FLNa-Hinge 1 Region EGFP
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the fibronectin pattern, indicating lower structural rigidity
(Figure 4C). Cells without FLNa (M2) seemed much more plastic
and adaptable to a given shape than their partners with FLNa (A7
and M2-FLNa-EGFP) (Figure 4B). In fact, the cells expressing
FLNa had a common characteristic of drawing poorly defined T
and I shapes, revealing that the more rigid architecture of these
cells was due to the presence of FLNa. When comparing A7 vs. C5
cell shapes, the phenotype of C5 resembled the one of A7. These
observations suggest that the levels of FLNa are important for the
correct establishment of the FLNa-EGFP clones. We also used the
micropatterns to study the cellular localization of filamin A and
actin. Interestingly, images revealed an intensive colocalization of
actin and FLNa in the boundaries of the cell, especially in leading
edge, indicating hot spots for structural reorganization and
directional migration.
Migration speed of M2 cells is enhanced in cells
expressing appropriate levels of FLNa-EGFP
As FLNa-deficient cells are known to have impaired transla-
tional migration [23], we sought to investigate if FLNa-EGFP
could also restore this function. Time-lapse studies following the
migration of cells over time (Figure S2, lower panels) were first
acquired with a mixed population of M2-FLNa-EGFP stable cells.
A7 (middle panels) and M2 (upper panels) cells were followed as
positive and negative controls, respectively. The average M2 cell
(without FLNa) showed a reduced capacity to move on the plate,
as has previously been reported [23]. On the contrary, most of the
A7 cells were moving. Figure S2 shows an example of the
movement of a single A7 cell on the plate. M2-FLNa-EGFP cells
that had a more elongated phenotype were also able to migrate
similarly to the A7 cells.
We then studied the effect that the different expression levels of
FLNa-EGFP would have on cell migration by using two clonal cell
lines C4 and C5, expressing different filamin A levels, in a wound-
healing assay. As mentioned before, C5 had similar levels of FLNa
as the A7 cells. Confluent A7 and M2 cells and stable cell clones 4
(C4) and 5 (C5) were wounded and allowed to migrate into the
cleared area (Figure 5A). Employing ImageJ software, the rate of
wound closure was analysed determining the size of the area of the
wound for each cell line and time point (Figure 5B). Untransfected
M2 cells covered ,57.5% of the wound area after 24 h and
,74% after 48 h, while wild-type A7 cells and clone 5 covered
,68% and ,77% wound closure after 24 h and showed near
complete wound closure after 48 h (A7: ,99% and C5: ,99%).
Interestingly, the high FLNa-EGFP level expressing clone 4
performed even worse than the M2 cells showing only ,17%
wound closure after 24 h and ,51% wound closure after 48 h
(Figure 5A and B) As mentioned before, the high levels of FLNa
induces the cells to grow in circular patterns. These results suggest
that overexpression of FLNa-EGFP decreases cell locomotion,
while expression of the appropriate levels of FLNa-EGFP restores
the migration speed to the level of A7 cells, implying that the
chimeric protein is functional when expressed at the adequate
levels. These results also corroborate the essential role that this
actin-crosslinking protein has on directionally migration and that
the EGFP fusion construct is a useful tool for visualizing these
processes.
Efficient CCL2-mediated internalization of CCR2B is
restored using the fusion construct
Previous work from our group has demonstrated that FLNa
binds to the C-terminal intracellular tail of the chemokine receptor
CCR2B [17]. In order to track the internalized receptor and
filamin A, experiments were designed in FLNa-deficient M2 cells
expressing the CCR2B receptor and FLNa-EGFP and FLNa
siRNA-treated HEK293 cells (Figure 6). We used CCR2B-
expressing A7 and M2 cells as control. There was poor
internalization of the receptor, in absence of FLNa after 15 and
30 min of ligand incubation in M2 cells and complete inhibition of
internalizaion in FLNa siRNA-treated cells that express low levels
(20%) of FLNa (Fig S3). However, in A7 and FLNa-EGFP-
repleted M2 cells, most of the receptor was internalized after 15
and 30 min of CCL2 challenge (Figure 6). This can be clearly seen
following the percentage of co-localization (Pearson coefficient,
expressed in %) which increased with the time after ligand
addition reaching values of 64% after one hour. So these results
demonstrate that FLNa-EGFP is necessary for the internalization
of ligand-induced CCR2B receptor. Then, experiments were
designed to follow the receptor after CCL2 stimulation in presence
of FLNa-EGFP in vitro and in real-time (Figure 7). For that, cells
stably expressing the FLAG-tagged CCR2B receptor and tran-
siently transfected with FLNa-EGFP were pre-incubated with the
pre-labeled anti-FLAG antibody and then challenged with CCL2
under confocal microscopy (spinning disk) (Figure 7A). The
receptor present at the plasma membrane moved inside the cells
and co-localized with FLNa-EGFP containing fibers. Some of the
vesicles containing the receptor can be seen moving along filamin-
labeled fibers, which are likely to be actin fibers (Figure 7A arrows,
7B). Tracking of the particles (CCL2-stimulated CCR2B receptor)
utilizing the Imaris software which depicts movements of particles
with the time in a color coded diagram, allowed a better
visualization of the trajectory of the receptor (Figure 7C). The
particles represent the individual receptor internalized in endo-
somes. At early times particles are located at or close to the
membrane (Figure 7C, violet color). A ring of particles moving
around the nuclei is apparent in later times after ligand addition
(Figure 7C, yellow-white colours, dotted line) which suggests that
vesicles with internalized receptor were concentrating around the
perinuclear region of the cell and that they did so by traveling
along filamentous structures containing FLNa. Also, some particles
moving at the edge of the cell appear at later times (Figure 7C,
arrow).
To better assess if the internalized particles containing the
ligand-stimulated CCR2B receptor were endosomal vesicles, cells
were transfected with the receptor together with Cherry-Rab5 in
presence if FLNa-EGFP (Figure 8, see also film in Fig S4). As can
be seen, at early times the receptor (in blue) is localized at the
plasma membrane together with FLNa (green) (Figure 8A), 4 min
after ligand-activation the receptor internalizes and co-localizes at
early endosomes with Cherry-Rab5-containing vesicles (red,+-
blue+green = violet) close to the cortex of the cell. It is possible to
observe some of these vesicles containing the receptor and Rab5
moving along FLNa-containing structures (Figure 8A, 7 and
7.5 seconds. Figure 8B and C). These results then confirm that the
internalized receptor in early endosomes moves along filamin
containing fibers.
Since FLNa interacts with ß-arrestin2, which is involved in the
process of internalization of other GPCRs like the ß2-adrenergic
equal to the area covered by fibronectin = low cell rigidity). The experiment was repeated three times and 30 cells were analyzed per point. Results
were plotted in a chart with (6 SEM).
doi:10.1371/journal.pone.0040864.g004
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receptor ([25]), it is possible that this effect is not only observed
with the CCR2B receptor. Experiments with time-lapse confocal
microscopy were also performed with cells expressing the ß2-AR,
together with Cherry-Rab5 and FLNa-EGFP (Figure S5). As
expected, the ß2-AR internalized and localized to the early Rab5-
labeled endosomes upon isopreterenol treatment. Early endosomes
were also seen along some FLNa-positive fibers. Interestingly
though ß2-AR-internalized vesicles localized with FLNa-EGFP
only at very early time points (Figure S4, 03:56). These results
agree with the fact the ß2-AR receptor dissociates from ß-arrestin2
at early times after internalization [26]. Together, these results
support the notion that the binding to filamin facilitates the
internalization of the ligand-stimulated GPCRs into endocytic
vesicles.
Discussion
In this paper, we have described a novel fluorescent FLNa tool
and demonstrated its functionality and usefulness for visualizing
the dynamic involvement of FLNa in various cellular processes
employing live cell-imaging. The novelty of our tool arises from
the strategic insertion of the fluorescent EGFP tag inside the
flexible hinge 1 region of FLNa. More importantly, we demon-
strated that the FLNa-EGFP protein restores the impaired
internalization of the CCL2-stimulated CCR2B receptor in
FLNa-deficient cells and demonstrated for the first time that
filamin accompanies the receptor in endocytic vesicles, providing
evidence for the involvement of actin structures in the internal-
ization process of GPCRs.
In addition to crosslinking filamentous actin, FLNa also acts as
an intracellular signalling scaffold for a large variety of membrane
receptors and signalling molecules involved in cell adhesion and
locomotion [1]. The list of protein partners that filamin A binds to,
which so far includes over 60 members, is growing at an incredible
speed, thus reflecting the impact of this protein on a wide range of
cellular functions. So the design of a functional imaging tool to
track FLNa would help to determine the role of this protein in vitro
and in real-time. For that, it was crucial to choose a location for
the EGFP-tag that would not compromise any of the important
physiological function of FLNa. While the N-terminal ABD [5,6]
and Rod 1 [8] domains of FLNa are important for actin binding,
the C-terminal domain is required for FLNa dimerization [7]. The
dimerization of filamin is essential for its capacity to gelate actin
filament structures. Also, the Rod 2 domain is the binding site for
the vast majority of the intracellular interaction partners of FLNa
[9]. The two hinge regions of filamin A show the greatest sequence
divergence. Their main function is to provide flexibility and
structural adaptability to the protein, though a recent study
demonstrated that the hinge 2 region is also required for
dimerization of FLNa, and for its interaction with the dimer of
Figure 5. FLNa-EGFP restores wound healing velocity of M2 cells. (A) Brightfield and immunofluorescent images of wound closure in
different cell lines. Confluent monolayers of A7, M2 and selected M2-EGFP-FLNa cell clones (C5 and C4) were scratched with a pipette tip and images
were taken at 0, 24, and 48 h after wounding, as indicated. Images were taken with 46magnification using a PhL filter. Experiments were done in
duplicates and repeated three times. (B) ImageJ quantification of the wound-healing assay analysing the area of the wound for each time point and
cell type (A7, M2, C5 and C4). Results plotted as a % of the wound closure per time point.
doi:10.1371/journal.pone.0040864.g005
Figure 6. FLNa-EGFP binds and internalizes CCR2B.M2 cells (first column left panel), A7 cells (second column left panel) and HEK293 cells were
transfected with pcDNA3-FLAG-CCR2B. Central panel shows HEK293-CCR2B cells treated with 100 nM of FLNa siRNA. M2 cells were transfected with
pcDNA3-FLAG-CCR2B and FLNa-EGFP (right panel). Cells were further incubated with CCL2 for the times indicated and stained for CCR2B (red). The
images were deconvolved using a theoretical point spread function before analysis of colocalization. Colocalization is shown in white with Pearson
coefficient expressed in %. Images are from one single layer of the Z stacks. White dotted lines show the contour of the cells. Experiments were done
in duplicates and repeated three times in each experiment an average of 20 cells were analyzed. Scalebars (10 mm).
doi:10.1371/journal.pone.0040864.g006
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the Rac-specific FLNa-binding GTPase FilGAP [27]. The first
hinge region between repeats 15 and 16 is mainly important for
maintaining the viscoelastic properties of the actin networks.
Actually, when a recombinant filamin lacking this hinge region
was expressed, the mutant could still form actin networks,
although they broke at lower stresses [28]. Here we have proven
that the chimera protein is fully functional, which supports the
idea that the hinge region 1 was structurally adequate for placing
the EGFP. One of most striking differences between the M2 and
A7 cells are their different capacities to form cell shapes on the
micropattern fibronectin surfaces of the CYTOO arrays, due to
their different adaptabilities. It has been proven that cells depleted
Figure 7. Time lapse of the Internalization of the CCL2-stimulated CCR2B in HEK293 cells expressing FLNa-EGFP. (A) Upper row:
snapshots from spinning disk experiments with HEK293 cells showing the distribution of CCR2B (red) and FLNa-EGFP (green) in different time points.
Arrow depicts vesicles located to filamin A-containing fibers. Lower row: colocalization analysis shown in white. (B) ROI analysis of the CCRB
internalization at the time interval from 14 to 15 min showing the movement along the stress fibers. (C) Tracking analysis using Imaris software
shows the CCR2B trajectory (red balls) after CCL2 stimulation from time 0 min (left) until time 20 min (right). Tracking lines are color-coded ranging
from purple (0 min) until yellow (20 min). Arrow depicts the leading edge of the cell. Scalebars (10 mm).
doi:10.1371/journal.pone.0040864.g007
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of FLNa respond to mechanical forces [29]. Clearly FLNa-
deficient cells adapted better to the shapes on the array than A7
cells or M2-FLNa-EGFP cells. Probably this effect is caused by the
fact that under mechanical stress, FLNA-deficient cells elevate the
levels of Rac whereas Rho activity decreases. In contrast, FLNa-
expressing cells increase their Rho activity and number of stress
fibres, which results is less adaptability to the T and I shapes.
Another challenge of placing the tag in this region was to avoid
blocking calpain cleavage. Calpain cleavage is important for
functional migration [20,21] and for transcriptional regulation, as
the cleaved 100 kDa C-terminal domain of FLNa has been found
to localize to the nucleus with several transcription factors [16,30],
so to make sure that the fusion protein would be cleaved in this
region, we also introduced and artificial calpain-cleavage site in
front of the tag. It has been shown before that deletion of the
calpain-cleavage site does not completely prevent calpain cleavage
[31], so a potential obstruction of the natural calpain cleavage site
could still lead to cleavage at another location. However,
immunoblotting experiments indicated that both calpain-cleavage
sites in the H1 region were equally functional and that FLNa-
EGFP seemed to be cleaved either before or after the tag.
Although the construct was partially cleaved in front of the EGFP-
tag, we did not observe any FLNa expression in the nucleus in our
preliminary experiments. This was probably due to low levels of
the cleaved product, as only a small fraction of FLNa-EGFP is
cleaved by calpain. Further research in different cell types and
under various conditions utilizing FLNa-EGFP will help to study
the role of the calpain cleavage in FLNa physiology.
Immunostaining experiments indicated that the FLNa-EGFP
fusion protein colocalized with F-actin at the plasma membrane
and in fibres as the wild type protein, implying that it was correctly
expressed and able to interact with actin through its N-terminal
ABD. In addition, we observed that FLNa-EGFP could restore
translational migration in the FLNa-deficient M2. A combination
of SEM and fluorescent microscopy allowed us to perform a
detailed study of the morphology and cytoskeletal structures of M2
cells stably expressing the construct, revealing that FLNa-EGFP
was also capable of cross-linking actin filaments as these cells had a
high occurrence of surface stress fibres, decreased membrane
blebbing and a more elongated phenotype, like the A7 cells [32].
One of the interesting observations of our research was the fact
that the levels of expression of filamin A are crucial for obtaining a
functional migrating cell. As so, both low and excessive levels of
FLNa can inhibit cell migration [23]. Therefore, only few clones
with moderate levels of filamin A expression behaved like A7 in
cell cultures, growing dispersedly, displaying an elongated
morphology and migrating similarly to the A7 cells. Excessive
levels of FLNa-EGFP expression had a negative impact on cell
growth and migration. The experiments evaluating cell rigidity
and migration velocity during wound healing confirmed the need
for adequate levels of filamin A for proper cell behaviour.
In a recent study from our group, we demonstrated that FLNa is
required for the efficient internalization of the CC-chemokine
receptor CCR2B, and that downregulation of FLNa in THP-1
monocytes prevented CCL2-mediated chemotaxis [17]. CCL2/
CCR2B are involved in wide range of pathologies including
multiple sclerosis, rheumatoid arthritis, atherosclerosis, cancer,
and HIV-1 pathogenesis [33]. As mentioned before, we had
previously demonstrated utilizing two-hybrid technology that the
C-terminal tail of CCR2B binds to filamin through at least the
repeat 19 domain. The interaction of FLNa with CCR2B appears
to be necessary for the internalization step of the receptor into
endocytic vesicles, but the results also seemed to indicate that
further steps of vesicle trafficking could be involved. It was
therefore necessary to confirm this novel role for filamin A in
CCR2B trafficking. The results presented with the FLNa-EGFP
clearly show that the internalized receptor localized with the
FLNa-EGFP protein in a punctate pattern in the cytoplasm after
internalization. So combined with our data demonstrating that
knock-down of FLNa by RNA interference technology abrogates
receptor internalization, these results demonstrate that filamin is
present and necessary for the internalization and the trafficking of
vesicles with the CCR2B receptor. Live cell imaging experiments
enabled us to follow the dynamic involvement of FLNa and
CCR2B during internalization. First, the movies showed that
FLNa is an extremely motile protein, which is rapidly shuttled to
cellular hot spots where, most likely, its actin-crosslinking or
protein-scaffolding functions are needed. On the other hand,
CCL2-stimulated CCR2B was seen travelling in vesicles along
filamin A-containing actin filaments that concentrated around the
perinuclear region. It is well know that late endosomes localize in
those areas, but it is not so clear that the filamin A protein through
Figure 8. Time lapse of the Internalization of the CCL2-
stimulated CCR2B in HEK293 cells expressing Cherry-Rab5
and FLNa-EGFP. HEK293 cells were transfected with pcDNA3-Flag-
CCR2B, pCherry-Rab5 and pcDNA3.1-FLNa-EGFP. Cells were incubated
with anti-flag M1 antibody followed by anti-mouse-Alexa647 antibody
at 4uC. Cells were place in the 37uC microscopy chamber and stimulated
with 20 nM CCL2. (A) Snapshots from Leica confocal SP5 microscope-
time lapse experiments with CCL2-stimulated HEK293 cells (from 0 to
8 min) showing the distribution of CCR2B (blue), Cherry-Rab5 (red) and
FLNa-EGFP (green) in different time points. Red arrow depicts the
localization of the receptor at the plasma membrane; yellow are vesicles
labeled with Cherry-Rab5 and FLNa-EGFP: violet are Rab5-vesicles
containing CCL2-stimulated CCR2B, which are located to FLNa-
containing fibers. (B) Snapshots of the CCRB internalization at the time
interval from 500 to 555 s showing the movement of Rab5 and receptor
positive vesicles along filamin A-containing fibers. Arrow heads indicate
the position of two moving vesicles. (C) Detail analysis from B. Scale
bars (10 mm). Dotted lines indicate the path of the filamin A possitive
fiver.
doi:10.1371/journal.pone.0040864.g008
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its binding to actin filaments is required for bringing the CCR2B-
endosomes there.
Both endosomes and endogenous vesicles can be propelled
through the cytoplasm by actin comet tails and this process has
been described for several vertebrate species [34]. Although the
exact function of these structures has not been thoroughly
characterized, it has been proposed that comet tails might
facilitate the movement of organelles towards cytoskeletal struc-
tures or aid the fusion of endocytic vesicles [34]. Active actin-
filament assembly seems to provide the motor for pushing the
endosomes along and both Arp2/3 (actin-related protein 2/3)
complexes [34] and the large GTPase dynamin (Dyn2) [35] have
been described as components of actin comet tails. Furthermore
actin dynamics are controlled by RhoB and mDia, both localized
in endosomes, which contribute to the process of vesicle movement
[36]. Due to its multitude of interaction partners, it is appropriate
to assume that during this vesicle transport, FLNa is associated
with signalling molecules important for RhoGTPase-mediated
cytoskeletal remodelling. It has been shown before that FLNa
interacts with proteins such as the actin-regulating Ras-related
small GTPases RhoA, Rac1, Cdc42 and RalA [15], the guanine
nucleotide-exchange factor (GEF) for Rac1 and RhoG, Trio [37],
the RhoGEF Lbc [38] and the RhoGTPase effectors Pak1 [39],
ROCK [40] and FilGAP [41]. It is also known that FLNa
associates dynamically with Golgi membranes during budding and
trafficking of transport vesicles and has been shown that in
periventricular nodular heterotopia, a developmental FLNa loss-
of-function disease, this vesicle transport is disrupted [42,43]. This
suggests that FLNa not only functions as a structural protein, but
also, that it has an important role as a cargo protein for the
transport of components to dynamic cellular locations. Therefore,
taken together our findings suggest that one of the functions of
FLNa is to transport vesicles with the stimulated chemokine
receptor to these dynamic cellular locations where it will
redistribute it. Particularly interesting is the finding that some of
the vesicles with CCL2-stimulated CCR2B headed towards the
leading edge of the cell.
In conclusion, these findings open up new opportunities to use
this tool for investigating and characterizing the potential
interaction of FLNa with chemokine receptors and its role in the
vesicular trafficking.
Materials and Methods
Cell culture
Human melanoma cell line M2 (lacking expression of FLNa)
and isogenic cell line A7 (stably expressing full-length FLNa)
(provided by J. Hartwig, Harvard Medical School, Boston, MA,
USA) were maintained in a-minimal essential medium (MEM)
supplemented with 8% (v/v) newborn calf serum, 2% (v/v) fetal
calf serum (FBS) [23]. A7 and M2-FLNa-EGFP cells were cultured
in the presence of 500 mg/ml G418. Cells were maintained in a
humidified atmosphere of 5% CO2 at 37uC. FLAG-CCR2B
expressing HEK293-stable and HEK293 cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% (v/v) FBS and 250 mg/ml G418.
DNA Constructs
The pcDNA3.1-FLNa-EGFP vector was derived from pREP4-
FLNa (provided by J. Hartwig, Harvard Medical School, Boston,
MA, USA) and pEGFP-N1 (Clontech, Sant-Germain-en-Laye,
France) using PCR. The FLNa sequence from pREP4-FLNa was
amplified in two pieces resulting in an N-terminal fragment (aa 1–
1742) and a C-terminal fragment (aa 1743–2647). The EGFP
fragment was amplified from the pEGFP-N1 and subsequently
inserted in between the N-terminal and C-terminal FLNa
fragments in a pcDNA3.1 vector. The FLNa N-terminal fragment
was amplified utilizing the forward primer: 59CTC GCT AGC
CTG AAA ATG AGT AGC TCC CAC, and reverse: 59CCC
AAG CTT CAG AGC CAG AGC CG. The C-terminal fragment
was amplified utilizing the forward primer 59CCC AAG CTT
CTC GGG GAC CAG CCC TC, and reverse: 59GAG GCG
GCC GCT CAG GGC ACC ACA AC. For the EGFP fragment,
forward: 59GGA AAG CTT GCG ATG GTG AGC AAG GGC,
and reverse: 59CCG AAG CTT GGA CTT GTA CAG CTC
GTC. Sequencing was performed in order to determine the
correct insertion of EGFP in the hinge 1 region of FLNa. pCherry-
Rab-5 was derived from Rab5-GFP (provided by P. van der Sluijs,
University Medical Center Utrecht, The Netherlands) using PCR
and cloning into pCherry-C1 (Clontech Laboratories, Inc, USA)
in XhoI and HindIII. The Flag-tagged ß2-adrenergic receptor in
pcDNA was a kind gift of F. Mayor (Centro de Biologia
Molecular, Madrid, Spain).
FLNa-EGFP homology modeling structure
To estimate the 3D structure of the generated FLNa-EGFP
hinge 1 region, an automated homology modeling prediction was
calculated by uploading the target sequence to the Swiss-model
server (SIB, Lausanne, Switzerland).
Establishment of stable clones
M2 cells were transiently transfected with pcDNA3.1-FLNa-
EGFP using Fugene 6 (Roche Diagnostics, Basel, Switzerland)
according to the manufacturer’s instructions. After two days, the
culture medium was replaced with medium containing G418
(1000 mg/ml). Resistant colonies were sorted twice using a BD
FACSAria SORP flow cytometer to select for cells expressing high
fluorescence. From the mixed population, cells were serially
diluted into multiwell plates and nine clones (C1–C9) were picked
and cultured separately. Cells were further cultured in medium
containing 500 mg/ml G418.
Immunoblotting
For checking the expression of the chimera, A7 and M2 cells
were transiently transfected with pcDNA3.1-FLNa-EGFP or
pcDNA3.1 using Fugene 6 according to the manufacturer’s
instructions. After 48 h, cells were washed in ice-cold 1x PBS,
before being solubilized in 0.5% NP-40 lysis buffer (50 mM Tris,
pH 7.4, 150 mM NaCl, and 0.5% NP-40) containing 1 mM
EDTA, 0.1 mM Na3VO4 and a cocktail of protease inhibitors.
After clarification, the lysates were resolved on SDS-PAGE and
transferred to nitrocellulose membranes. The presence of FLNa
and FLNa-EGFP was detected using anti-filamin 1 (Santa Cruz
Biotechnologies, CA, USA) and anti-GFP (Abcam, Cambridge,
UK) antibodies. For assessing the expression levels of FLNa-EGFP
in the isolated stable cell clones, the same number of A7, M2 and
M2-FLNa-EGFP cells were seeded in 100 mm plates. Twenty-
four hours after plating, cells were washed, lysed and subjected to
immunoblotting as described before. The presence FLNa, FLNa-
EGFP and b-actin was detected using anti-filamin 1 and anti-b-
actin (Abcam) antibodies. Blots were developed using an enhanced
chemiluminescent method (Pierce, Thermo Scientific, Rockford,
USA) and scanned using the LAS-3000 imaging system (Fujifilm,
Tokyo, Japan).
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Scanning electron microscopy (SEM) and correlational
microscopy
Scanning electron microscopy for the structural characteriza-
tion of M2, A7 and M2-FLNa-EGFP cells was performed as
follows: after dehydration in graded alcohols, cells seeded on top of
coverslips were dried by the critical point method, mounted on
cylinders with double-coated adhesive tape and covered with a
thin layer of gold/palladium in an anion sputter coating unit.
Scanning electron microscopy was carried out using a Jeol JSM-
7400F scanning electron microscope (Jeol ltd. Tokyo, Japan) at an
acceleration voltage of 5.0 kV and a working distance of 7.7 mm
in high-vacuum mode. For the correlational microscopy, samples
used for the SEM were first pictured with a Nikon TE2000
inverted fluorescent microscope (Nikon, Tokyo, Japan), using
marked positions in the coverslip in order to identify the cells after
the SEM treatment. Finally, SEM and widefield fluorescent
images were overlapped employing the graphic software package
Adobe PhotoShop CS4.
Wound healing assay
Monolayers of A7, M2, C4 or C5 cells were wounded 24 h after
plating in a 12-well plate by scratching with a 200 ml pipette tip.
Debris was removed by washing. Images of the wound were taken
at 46magnification (Nikon PhL; NA 0.13) at times 0, 24 and 48 h
after wounding using a NikonTE2000 inverted fluorescence
microscope equipped with a MuTech MV 1500 camera (Nikon
Instruments Europe B.V., The Netherlands). Wound closure was
quantified using the Image J software by measuring the total size of
each wound area at different time points.
Immunostaining and confocal microscopy
To analyze the subcellular localization of FLNa-EGFP, A7 and
M2 cells were seeded on coverslips and M2 cells were transiently
transfected with pcDNA3.1-FLNa-EGFP or pREP4-FLNa using
Fugene 6. Cells were then washed in PBS, fixed and permeabilized
in PBS with 0.1% Tween 20 before staining with mouse anti-
filamin 1 (Santa Cruz Biotechnologies, CA, USA), Alexa Fluor 488
goat anti-mouse (Invitrogen, CA, USA) or Texas Red goat anti-
mouse (Invitrogen, CA, USA) and Rhodamine-Phalloidin (In-
vitrogen, CA, USA). All coverslips were mounted using Prolong
Gold mounting medium with DAPI (Invitrogen, CA, USA).
Optical sections were acquired using a Leica TCS SP2 AOBS
confocal system equipped with a 63x Ibd.BL oil objective.
Colocalization analyses were performed using the Imaris coloca-
lization module (Bitplane AG, Zurich, Switzerland).
Live cell imaging
For long term live cell imaging, a TCS SP2 and SP5 confocal
microscopes (Leica Microsystems) equipped with a 37uC incuba-
tion chamber with 5% CO2 were used. For mitosis, wound-
healing and receptor internalization, cells were stimulated with
40 nM CCL2. ß2-AR-transfected HEK293 cells were stimulated
with 10 mM of isoproterenol. After adding of the ligand, four slice
Z-stacks were taken every 2 min for 14 h for mitosis and wound-
healing experiments. The collected images from the time-lapse
imaging were processed using Imaris (Bitplane) and mounted as
.AVI files with a frame rate of 14 fr/sec. For short-term live
imaging, a Perkin-Elmer Ultraview spinning wheel confocal
system mounted on a Zeiss Axiovert 200 microscope and
equipped an Orca-ER Firewire Camera CCD camera (Hama-
matsu, Hamamatsu City, Japan) and with a 37uC incubation
chamber with 5% CO2 was used. Z-stacks of the images were
collected using a 63X NA 1.4 oil objective with Argon excitation
laser at 488 nm and Helium-Neon Laser at 543 nm. HEK293
cells stably expressing FLAG-CCR2B were incubated during 1h at
4uC with anti-FLAG M2-Cy3 antibody (Sigma-Aldrich Co). Z-
stacks were acquired continuously in the spinning disk with
300 millisecond exposures during 60 min after addition of 1 ml of
40 nM CCL2 on top of the plate with 1ml of DMEM medium
without phenol red. Experiments for receptor internalization
together with Cherry-Rab5 were done in a confocal SP5
microscope (Leica Microsystems) acquiring one plane (x/y/t)
every two minutes time point. HEK293 cells were trasient
transfected with pcDNA3-FLAG-CCR2B or FLAG-ß2AR in
presence of Cherry-Rab5 and pcDNA3.1-FLNa-EGFP. The
pinhole was set to 3 to diminish image bleaching and to increase
acquisition speed. Green, red and far red channels were captured
sequentially. Images were processed using Imaris (Bitplane AG) or
Fiji software and mounted as .AVI file with a frame rate of 7 or
14 fr/sec. Colocalization analyses were performed using the
Imaris colocalization module (Bitplane AG).
Tracking analyses
Tracking analyses of the CCR2B trajectory were done using the
4D tracking module from Imaris software (Bitplane AG) uploading
the z-stack captured by spinning disk, segmentating CCR2B
receptors to red spheres and drawing the trajectories of
movements of the red spheres. Tracking provided qualitative
information regarding the fluorescence intensities of the CCR2B
receptor (red balls), particle’s trajectory and calculated displace-
ments. The color coded diagram ranging from 0 min (purple) until
20 min (yellow) shows the kinetic of the receptor through time.
Arrow depicts the leading edge of the cell.
Adhesive micropatterning assay
In order to normalize the cell architecture for studying FLNa,
A7, M2 and C5 cells were plated 4 h at 37uC on glass coverslips
microprinted with fibronectin patterns (CYTOO, Grenoble,
France). Cells were fixed, permeabilized and incubated with
primary and secondary fluorescent antibodies as follows: for A7
and M2 cells, mouse anti-filamin 1, Alexa 488 goat anti-mouse
(Invitrogen) and Rhodamine-phalloidin (Invitrogen) were used,
while Rhodamine-Phalloidin was used for the C5 cells. Finally,
samples were mounted using DAPI Prolong Gold mounting
medium (Invitrogen) and optical sections were acquired using a
Leica TCS SP2 AOBS confocal system. Colocalization analyses
were performed using the Imaris colocalization module (Bitplane).
To quantify the rigidity of the cells with or without FLNa, the
imageJ (NIH) software was used to measure the area in pixels of
the cell attached to the pattern and the area in pixels of the
fibronectin pattern. The ratio of rigidity was calculated dividing
both values from 30 random cells per type and shape and plotting
the average results (6SEM) in a chart.
CCR2B internalization assay in presence of FLNa siRNA
A synthetic FLNa-targeted siRNA oligoribonucleotide duplex with
symmetric 39TT overhang (FLNa siRNA sense sequence: 59-
AGGUGCUGCCUACUCAUGA-39, [44]) was purchased from
Dharmacon RNA Technologies (USA, Lafayette, CO). The following
two oligoribonucleotides were used as negative control: siGENOME
negative control siRNA #3 (Dharmacon), AllStars negative control
siRNA (Qiagen). HEK293 cells stably expressing FLAG-CCR2B
were transiently transfected with 100 nM synthetic control siRNA or
FLNa siRNA using LipofectamineTM 2000 reagent (Invitrogen), and
incubated 5 days at 37uC [17]. Cells were then washed in ice-cold
PBS before being solubilized in 0.5% NP-40 lysis buffer (50 mM Tris,
pH 7.4, 150 mM NaCl, and 0.5% NP-40) containing 1 mM EDTA,
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0.1 mM Na3VO4 and a cocktail of protease inhibitors. After
clarification, the lysates were resolved on SDS-PAGE and transferred
to nitrocellulose membranes. Cells to be used for the internalization
assay were trypsinised 4 days after transfection and replated onto poly-
L-lysine-coated glass coverslips. After 24 h, cells were incubated with
mouse anti-FLAG-M2-Cy3 antibody (Sigma-Aldrich Co.) at 4uC and
stimulated with 20 nM CCL2 at 37uC for the times indicated before
being fixed, and incubated with goat anti-FLNa (Santa Cruz
Biotechnology, Inc.) followed by FITC-conjugated mouse anti-goat
(Jackson ImmunoResearch, Suffolk, UK).
Supporting Information
Figure S1 (A) Immunofluorescence images of the cell morphol-
ogy and expression pattern of FLNa-EGFP in three selected M2
clones (C5, C8 and C4) stably expressing FLNa-EGFP. Images are
superposed on top of the bright-field images taken from the same
area of the plates (magnification 20x). (B) Immunoblot showing the
levels of FLNa-EGFP in stable M2 clones C5, C8 and C4 versus
the levels of endogenous FLNa in A7 cells. M2 cells were used as
control. b-actin bands were used as a loading control. Experiments
were repeated twice with similar results.
(TIF)
Figure S2 Behavior of FLNa-EGFP in migration. Time-lapse
images from M2, A7 and M2 FLNa-EGFP cells from selected
areas showing the directional migration of the cells during 4 h.
Dotted lines mark the boundaries of the cell. The monochromatic
images are a segmentation from the bright-field images showing
one single cells per case (magnification 40x). Scalebar (10 nm).
(TIF)
Figure S3 Immunoblot quantification of FLNa knockdown in
HEK293-CCR2B cells treated with 100 nM siRNA as indicated.
Histogram represents the intensity of the FLNa bands, normalized
against the corresponding ß-actin bands. Experiments were
repeated twice with triplicate samples.
(TIF)
Figure S4 Movie from the SP5 Leica confocal images showing a
HEK293 transfected cell expressing FLNa-EGFP, Cherry-Rab5
and Flag-CCR2B labeled M1 with anti-flag antibody and
secondary Alexa 647 (shown in blue). The film shows the
internalization of Flag-CCR2B (blue) after CCL2 stimulation
and the co-localization with Rab 5 (red) during 30 min. The film is
from one single layer of the Z stacks and has been at converted to
1 frame every 5 seconds. Experiments were repeated three
times.
(AVI)
Figure S5 Time lapse of the internalization of the isoproterenol-
stimulated ß-2AR in HEK293 cells expressing Cherry-Rab5 and
FLNa-EGFP. HEK293 cells were transfected with pcDNA-ß-
2AR, pCherry-Rab5 and pcDNA3.1-FLNa-EGFP. Cells were
incubated with anti-flag M1 antibody followed by anti-mouse-
Alexa647 antibody at 4uC. Cells were place in the 37uC
microscopy chamber and stimulated with 10 mM isoproterenol.
Snapshot from Leica confocal SP5 time lapse experiments with
isoproterenol-stimulated HEK293 cells at 3:56 min showing the
distribution of ß-2AR (blue), Cherry-Rab5 (red) and FLNa-EGFP
(green) (upper panel). Lower panels show the snapshots of different
time points (3:56 to 4:28 min) with separate channels.
(TIF)
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